UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044170
Receipt number R000050438
Scientific Title Safety evaluation for combined use of 4 cosmetic preparations
Date of disclosure of the study information 2021/05/11
Last modified on 2021/08/31 09:11:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety evaluation for combined use of 4 cosmetic preparations

Acronym

Safety evaluation for combined use of 4 cosmetic preparations

Scientific Title

Safety evaluation for combined use of 4 cosmetic preparations

Scientific Title:Acronym

Safety evaluation for combined use of 4 cosmetic preparations

Region

Japan


Condition

Condition

Healthy Japanese women between the ages of 30 and 59

Classification by specialty

Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose is to confirm the safety of 4 test products after combined daily use for 8 weeks.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skin findings(Medical examination) : 0-8 weeks
Adverse events : 0-8 weeks
Subjective symptoms(Questionnaire, life diary) : 8 weeks

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Continuous use every morning and evening for 8 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

59 years-old >=

Gender

Female

Key inclusion criteria

1. Healthy Japanese women aged 30 to 59 at the time of screening test
2. A person who has received sufficient explanation about the test product as well as the purpose and content of this research, and then given written consent to participate in the research voluntarily.

Key exclusion criteria

1. Persons who have factors that affect the evaluation at the evaluation site including atopic dermatitis, trauma, burns, inflammation, acne, warts, etc.
2. Those who go to the hospital for treatment of an affected area on the face
3. Those who have a history of allergies to cosmetics
4. Those who are receiving hormone replacement therapy
5. Those who are pregnant or breastfeeding, or those who will not use proper birth control because of wishing to become pregnant during the period from the time of giving consent to the end of the study.
6. Those who have received cosmetic medicine that affects the evaluation site, or those who plan to receive it during the research period
7. Those who have undergone special skin care treatment (facial treatment, etc.) that affects the evaluation site within 4 weeks before the start of application of the test product, or those who are planning to receive it during the research period.
8. Those who received the test product in other clinical trials within 4 weeks before the start of application of the test product, or those who plan to participate in other trial during the research period
9. Those who are judged to be ineligible by the principal investigator or investigators with other reasons

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Kazuhiko
Middle name
Last name Takano

Organization

Medical Corporation Hokubukai Utsukushigaoka Hospital

Division name

Center for Clinical Pharmacology

Zip code

004-0839

Address

61-1, Sinei, Kiyota-ku, Sapporo, Hokkaido, 004-0839, Japan

TEL

011-882-0111

Email

takano@ughp-cpc.jp


Public contact

Name of contact person

1st name Takuya
Middle name
Last name Matsuda

Organization

Medical Corporation Hokubukai Utsukushigaoka Hospital

Division name

Center for Clinical Pharmacology

Zip code

004-0839

Address

61-1, Sinei, Kiyota-ku, Sapporo, Hokkaido, 004-0839, Japan

TEL

011-882-0111

Homepage URL


Email

matsuda@ughp-cpc.jp


Sponsor or person

Institute

Medical Corporation Hokubukai Utsukushigaoka Hospital

Institute

Department

Personal name



Funding Source

Organization

Noevir Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical corporation Hokubukai Utsukushigaoka Hospital Ethics Review Committee

Address

61-1, Sinei, Kiyota-ku, Sapporo, Hokkaido, 004-0839, Japan

Tel

011-881-0111

Email

matsuda@ughp-cpc.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 04 Month 16 Day

Date of IRB

2021 Year 05 Month 10 Day

Anticipated trial start date

2021 Year 05 Month 17 Day

Last follow-up date

2021 Year 07 Month 26 Day

Date of closure to data entry

2021 Year 08 Month 03 Day

Date trial data considered complete

2021 Year 08 Month 03 Day

Date analysis concluded

2021 Year 08 Month 06 Day


Other

Other related information



Management information

Registered date

2021 Year 05 Month 11 Day

Last modified on

2021 Year 08 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050438


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name